Vonoprazan-amoxicillin dual therapy vs. proton pump inhibitor based dual therapy for Helicobacter pylori eradication: a meta-analysis

Background and objectiveIn recent years, the use of high-dose dual therapy based on PPI and amoxicillin (PPI-HDDT) has shown satisfactory efficacy in eradicating Helicobacter pylori (H. pylori) as a first-line treatment. Vonoprazan (VPZ), a new potassium-competitive acid blocker, exhibits rapid, pot...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	You Lv, Hong-Hua Zhou, Jia-Geng Sun, Yu Qin, Ben-Gang Zhou
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2026-01-01
Sarja:	Frontiers in Medicine
Aiheet:	amoxicillin dual therapy Helicobacter pylori meta-analysis proton pump inhibitor vonoprazan
Linkit:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1739284/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!